The INTREPID Alliance seeks to catalyze the antiviral R&D ecosystem by creating and highlighting resources that can help drug discoverers and developers advance antiviral programs. Sometimes those actively engaged in drug discovery or early development efforts are faced with challenges that may slow down or even hinder progress; these may fall under different categories such as scientific/technical, regulatory, early clinical, manufacturing, or funding, to name a few.
Our team, with expertise in early-stage research and discovery through clinical research and commercialization, is available to discuss potential strategies and approaches to such challenges by way of our pro bono advisory services.
Please submit a request for a meeting using the form on this page. We will review your request and reply in a timely manner to arrange an initial, non-confidential discussion.